Delivery Order SPE2DB25D3202-SPE2DB25FTBAA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,102.40 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packaging) on July 21, 2025, with completion expected by July 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location at...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The delivery order, valued at $3,561.58, is for the supply of Lo Loestrin Fe 1-10 tablets, a contraceptive medication. The delivery order has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,098.24 firm-fixed-price contract is for the provision of Lo Loestrin Fe 1-10 tablet 28s, a birth control medication. The contract has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a $6,036.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the medication Lo Loestrin Fe 1-10 Tablet 28s. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is...
- This is a $1,857.36 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The order is for the drug Lo Loestrin Fe 1-10 Tablet 28s and has a completion date of June 23, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,427.28 firm-fixed-price contract is for the delivery of Lo Loestrin Fe 1-10 tablet 28s, a prescription contraceptive medication. The contract has an ultimate completion date of September 14, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Lo Loestrin Fe 1-10 tablet 28s. The $5,872.66 firm fixed-price contract has a performance period ending on March 28, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,352.35 delivery order contract is for the supply of Lo Loestrin Fe 1-10 Tablet 28s, a birth control medication. The contract has an ultimate completion date of August 9, 2022 and is a firm fixed-price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,077.38 firm fixed-price contract is for the delivery of 4,558,921,410 units of the contraceptive medication LO LOESTRIN FE 1-10 Tablet 28s. The contract has an ultimate completion date of October 31, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award is a $5,149.80 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the pharmaceutical product "LO LOESTRIN FE 1-10 TABLET 28S" and has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTBAADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,047.25 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 Tablet 28s, a hormonal contraceptive medication. The award, issued on July 25, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025. This non-competitive delivery order draws from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, fulfills this delivery order under its comprehensive federal contract vehicle that encompasses brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's substantial DLA contract portfolio reflects its capability to meet federal healthcare procurement requirements and support military medical supply chains worldwide, including services to the Defense Health Agency and U.S. Coast Guard. This particular delivery order exemplifies the routine pharmaceutical procurement activities managed through the company's established IDC framework with DLA Troop Support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/25/25 |